UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Claro Advisors LLC

Claro Advisors LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 3rd quarter, Holdings Channel.com reports. The firm owned 9,632 shares of the healthcare conglomerate’s stock after selling 308 shares during the period. Claro Advisors LLC’s holdings in UnitedHealth Group were worth $5,632,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 0.6% during the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD raised its position in UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after acquiring an additional 94,641 shares in the last quarter. Bank of New York Mellon Corp raised its position in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after acquiring an additional 35,533 shares in the last quarter. Dimensional Fund Advisors LP raised its position in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after acquiring an additional 21,149 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.2 %

Shares of UNH traded up $1.08 during trading on Friday, reaching $567.11. The company’s stock had a trading volume of 916,913 shares, compared to its average volume of 3,952,345. The company has a fifty day moving average of $584.20 and a two-hundred day moving average of $533.07. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company has a market cap of $523.68 billion, a price-to-earnings ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $6.56 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.68 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Analyst Ratings Changes

Several research analysts have issued reports on UNH shares. Morgan Stanley cut their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, Truist Financial restated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.